SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-028372
Filing Date
2024-02-08
Accepted
2024-02-08 16:17:55
Documents
19
Period of Report
2024-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d745010d8k.htm   iXBRL 8-K 32871
2 EX-1.1 d745010dex11.htm EX-1.1 160691
3 EX-5.1 d745010dex51.htm EX-5.1 81622
4 EX-99.1 d745010dex991.htm EX-99.1 9070
8 GRAPHIC g745010g0208174502623.jpg GRAPHIC 2970
9 GRAPHIC g745010g0208230145191.jpg GRAPHIC 2403
  Complete submission text file 0001193125-24-028372.txt   483730

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA autl-20240208.xsd EX-101.SCH 2849
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE autl-20240208_lab.xml EX-101.LAB 17925
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE autl-20240208_pre.xml EX-101.PRE 11236
20 EXTRACTED XBRL INSTANCE DOCUMENT d745010d8k_htm.xml XML 3725
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38547 | Film No.: 24609314
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)